David Valent

744 total citations
13 papers, 567 citations indexed

About

David Valent is a scholar working on Oncology, Rheumatology and Orthopedics and Sports Medicine. According to data from OpenAlex, David Valent has authored 13 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Rheumatology and 5 papers in Orthopedics and Sports Medicine. Recurrent topics in David Valent's work include Bone health and treatments (9 papers), Bone health and osteoporosis research (5 papers) and Heterotopic Ossification and Related Conditions (2 papers). David Valent is often cited by papers focused on Bone health and treatments (9 papers), Bone health and osteoporosis research (5 papers) and Heterotopic Ossification and Related Conditions (2 papers). David Valent collaborates with scholars based in United States, United Kingdom and Australia. David Valent's co-authors include Gary A. Cline, John F. Beary, Patrick Garnero, Philip G. Conaghan, Tim D. Spector, Joan M Meyer, Nelson B. Watts, M.D. Francis, Rebecca D. Jackson and Paul D. Miller and has published in prestigious journals such as The American Journal of Medicine, Journal of Bone and Mineral Research and American Journal of Ophthalmology.

In The Last Decade

David Valent

13 papers receiving 551 citations

Peers

David Valent

OSM

ONCOL

RHEUM

SURGE

Yusuke Kameda Japan

Karen Stoner United States

G.O. Stewart Australia

J. D. Ringe Germany

Mailze Campos Bezerra Brazil

Annalisa Avanzati Italy

Tomonori Kobayakawa Japan

Yasuo Noguchi Japan

C.V. Reda United States

E. Paresce Italy

Yusuke Kameda Japan

David Valent

57 ×0.2

OSM

76 ×0.3

ONCOL

50 ×0.2

RHEUM

168 ×1.2

76 ×0.7

SURGE

Citations per year, relative to David Valent David Valent (= 1×) peers Yusuke Kameda

Countries citing papers authored by David Valent

Since Specialization

Citations

This map shows the geographic impact of David Valent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Valent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Valent more than expected).

Fields of papers citing papers by David Valent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Valent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Valent. The network helps show where David Valent may publish in the future.

Co-authorship network of co-authors of David Valent

This figure shows the co-authorship network connecting the top 25 collaborators of David Valent. A scholar is included among the top collaborators of David Valent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Valent. David Valent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Watts, Nelson B., Charles H. Chesnut, Harry K. Genant, et al.. (2020). History of etidronate. Bone. 134. 115222–115222. 29 indexed citations

Thavikulwat, Alisa T., Naima Jacobs-El, Jane S. Kim, et al.. (2016). Evolution of Geographic Atrophy in Participants Treated with Ranibizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 1(1). 34–41. 15 indexed citations

Knickelbein, Jared E., William Tucker, Nirali Bhatt, et al.. (2016). Gevokizumab in the Treatment of Autoimmune Non-necrotizing Anterior Scleritis: Results of a Phase I/II Clinical Trial. American Journal of Ophthalmology. 172. 104–110. 25 indexed citations

Ebetino, Frank H., R.G.G. Russell, David Valent, & Nelson B. Watts. (2016). Marion David Francis: 1923–2016. Journal of Bone and Mineral Research. 31(10). 1783–1784. 1 indexed citations

Valent, David, James J. Augsburger, & Zélia M. Corrêa. (2012). EMBYRONAL CARCINOMA OF TESTIS METASTATIC TO CILIARY BODY PRESENTING AS SPONTANEOUS HYPHEMA AND PAINFUL SECONDARY GLAUCOMA. Retinal Cases & Brief Reports. 7(1). 105–107. 1 indexed citations

Valent, David, et al.. (2009). Type 2 Diabetes in the Pediatric Population: Are We Meeting ADA Clinical Guidelines in Ohio?. Clinical Pediatrics. 49(4). 316–322. 6 indexed citations

Francis, M.D. & David Valent. (2007). Historical perspectives on the clinical development of bisphosphonates in the treatment of bone diseases.. PubMed. 7(1). 2–8. 46 indexed citations

Heaney, Robert P., David Valent, & I Barton. (2005). Hospitalization-related bone loss and the protective effect of risedronate. Osteoporosis International. 17(2). 212–216. 7 indexed citations

Spector, Tim D., Philip G. Conaghan, Patrick Garnero, et al.. (2005). Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. Arthritis Research & Therapy. 7(3). R625–33. 196 indexed citations

10.

Roux, Christian, Ego Seeman, Richard Eastell, et al.. (2004). Efficacy of risedronate on clinical vertebral fractures within six months. Current Medical Research and Opinion. 20(4). 433–439. 128 indexed citations

11.

Miller, Paul D., Nelson B. Watts, Angelo A. Licata, et al.. (1997). Cyclical Etidronate in the Treatment of Postmenopausal Osteoporosis. The American Journal of Medicine. 103(6). 468–476. 107 indexed citations

12.

Chesnut, C. H., P. D. Miller, Anna Licata, et al.. (1996). Cyclical etidronate: Efficacy and safety over seven years. Osteoporosis International. 6(S1). 257–257. 1 indexed citations

13.

Miller, Paul D., Anna Licata, Richard D. Jackson, et al.. (1995). Seven years of cyclical etidronate: Continued improvement in spine bmd and progressive decline in vertebral fracture incidence. Bone. 17(6). 617–617. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact